CANCER RESEARCH CAREER ENHANCEMENT AND RELATED ACTIVITIES PROJECT SUMMARY/ABSTRACT Training the next generation of clinicians and researchers is a core mission of Yale Cancer Center (YCC). YCC has a long track record of providing infrastructure and funding for enhancing trainee research and advancing the careers of trainees and junior faculty across all YCC disciplines. YCC-supported education efforts have contributed to successful careers of trainees with diverse backgrounds, from students through junior faculty. Our vision is that YCC be a center of excellence in training the next generation of leaders in basic, translational, clinical, and population science cancer research. While cancer research training opportunities have long existed at YCC, improved coordination and developing cancer-specific training programs was identified as a top strategic objective in 2014, and in the 2017-2022 YCC Strategic Plan. The Cancer Research Training and Faculty Development Committee (Education Committee) was formed in 2015 to direct and support YCC training and faculty development. The Education Committee?s major goal is to bolster and coordinate training activities across disciplines. The Education Committee reviews classes and other training vehicles in the various training programs, and integrates trainees at all levels into programmatic activities via their association with one of the seven YCC Research Programs. Specific Education Committee activities include building training capacity; monitoring success; coordinating existing YCC education activities and providing additional opportunities by sponsoring seminars, workshops, and travel to scientific meetings; providing mentoring on proposal and career development; providing training in research of underserved populations; and recruitment of women and underrepresented minorities (URIM). Yale School of Medicine (YSM) has multiple cancer-specific and cancer-related training grants for pre- and postdoctoral trainees. Currently, YCC benefits from 17 institutional (T) training grants supporting trainees working with YCC Mentors. In addition, there are 11 active F awards and seven K awards from the NCI providing >$1.5M per year in support. The Education Committee reviews YSC training grants annually and identifies opportunities to integrate cancer-specific training. An important goal for the upcoming funding cycle is integration of training and education across disciplines: basic, preclinical, and clinical science, epidemiology, and outcomes. These elements are very strong individually and will benefit from increased integration that will encompass nursing, medical, and graduate students, postdoctoral trainees, residents, fellows, and junior faculty in cancer-related disciplines. Integration will be achieved through our Specific Aims.!

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA016359-40
Application #
9772266
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
Project End
Budget Start
2019-08-01
Budget End
2020-07-31
Support Year
40
Fiscal Year
2019
Total Cost
Indirect Cost
Name
Yale University
Department
Type
DUNS #
043207562
City
New Haven
State
CT
Country
United States
Zip Code
06520
Kelada, Olivia J; Decker, Roy H; Nath, Sameer K et al. (2018) High Single Doses of Radiation May Induce Elevated Levels of Hypoxia in Early-Stage Non-Small Cell Lung Cancer Tumors. Int J Radiat Oncol Biol Phys 102:174-183
Powles, Ryan L; Redmond, David; Sotiriou, Christos et al. (2018) Association of T-Cell Receptor Repertoire Use With Response to Combined Trastuzumab-Lapatinib Treatment of HER2-Positive Breast Cancer: Secondary Analysis of the NeoALTTO Randomized Clinical Trial. JAMA Oncol 4:e181564
Wang, Shi-Yi; Hsu, Sylvia H; Huang, Siwan et al. (2018) Regional Practice Patterns and Racial/Ethnic Differences in Intensity of End-of-Life Care. Health Serv Res 53:4291-4309
Gettinger, S N; Choi, J; Mani, N et al. (2018) A dormant TIL phenotype defines non-small cell lung carcinomas sensitive to immune checkpoint blockers. Nat Commun 9:3196
Liu, Huafeng; Li, Xin; Hu, Li et al. (2018) A crucial role of the PD-1H coinhibitory receptor in suppressing experimental asthma. Cell Mol Immunol 15:838-845
Altwerger, Gary; Bonazzoli, Elena; Bellone, Stefania et al. (2018) In Vitro and In Vivo Activity of IMGN853, an Antibody-Drug Conjugate Targeting Folate Receptor Alpha Linked to DM4, in Biologically Aggressive Endometrial Cancers. Mol Cancer Ther 17:1003-1011
Sanmamed, Miguel F; Chen, Lieping (2018) A Paradigm Shift in Cancer Immunotherapy: From Enhancement to Normalization. Cell 175:313-326
Gupta, Swati; Mani, Navin R; Carvajal-Hausdorf, Daniel E et al. (2018) Macrodissection prior to closed system RT-qPCR is not necessary for estrogen receptor and HER2 concordance with IHC/FISH in breast cancer. Lab Invest 98:1076-1083
Bellone, Stefania; Buza, Natalia; Choi, Jungmin et al. (2018) Exceptional Response to Pembrolizumab in a Metastatic, Chemotherapy/Radiation-Resistant Ovarian Cancer Patient Harboring a PD-L1-Genetic Rearrangement. Clin Cancer Res 24:3282-3291
Altan, Mehmet; Kidwell, Kelley M; Pelekanou, Vasiliki et al. (2018) Association of B7-H4, PD-L1, and tumor infiltrating lymphocytes with outcomes in breast cancer. NPJ Breast Cancer 4:40

Showing the most recent 10 out of 675 publications